Peter Garratt
UK & European Patent Attorney

Peter is the Senior Partner of Mathys & Squire and has 40 years' experience in building and exploiting patent portfolios, many the foundations of major businesses. Peter has spent much of his career advising his clients on the value of their IP and guiding them on how they can use this asset to benefit their business.

His skills before the EPO, particularly in opposition and appeal, are also put to use with multinational clients. Peter has considerable expertise in dispute resolution and is an accredited mediator. 

Peter has specific expertise working with clients in the Far East market and works closely with our China representative in Shenzhen. 


Year joined: 1974

Qualifications: MA (Oxon) EPA CPA RTMA


Peter's practice spans the creation, exploitation and enforcement of patent portfolios. He works with clients to ensure that patent budgets are spent wisely. He is highly experienced in representing clients before the EPO but also has broad experience of international patent prosecution. When advising his clients on the commercial exploitation of intellectual property, Peter is frequently involved not only in the drafting and negotiation of licences and other technology-based agreements, but also in the development of IP strategies, identifying new structures and opportunities for revenue generation. He is proficient in IP due diligence and related aspects of corporate finance. Peter works broadly in the fields of electronics and computing. He has expertise in medical devices and in a wide range of mechanical and electro-mechanical sectors.


Peter has a master's degree in physics from the University of Oxford and qualified as a Patent Attorney in 1978, winning the Gill Prize from the Chartered Institute.

Membership & Organisations

Peter is a member of the CIPA, AIPPI and FICPI.


  • Patent applications

  • patent drafting and filing
  • freedom to operate
  • due diligence
  • patent enforcement
  • IP strategy
  • patent portfolio management
  • licensing
  • patent oppositions
  • commercialisation 

Follow us on twitter